This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: Akira Kitabatake: Innovator in Hemoglobin Complexes
Introduction
Akira Kitabatake is a notable inventor based in Hokkaido, Japan. He has made significant contributions to the field of biochemistry, particularly in the development of innovative hemoglobin complexes. His work has implications for various medical applications, showcasing the intersection of science and technology.
Latest Patents
One of Akira Kitabatake's key patents is the "Nitric monoxide metabolite-polyoxyalkylene-hemoglobin complex." This invention discloses a complex with a molecular weight ranging from 100,000 to 2,000,000 daltons. In this complex, a polyoxyalkylene derivative is bound to 10 to 30% of the total bindable amino groups in hemoglobin. Additionally, a nitric monoxide metabolite is bound to 10 to 100% of the total thiol groups of cysteine residues. This innovative approach has the potential to enhance therapeutic applications.
Career Highlights
Throughout his career, Akira Kitabatake has focused on advancing the understanding of hemoglobin and its derivatives. His research has led to breakthroughs that could improve oxygen delivery in medical treatments. His dedication to innovation is evident in his patent, which reflects his expertise in the field.
Collaborations
Akira Kitabatake has collaborated with notable colleagues, including Kunihiko Nakai and Tohru Yasukohchi. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Akira Kitabatake's contributions to the field of biochemistry, particularly through his patented nitric monoxide metabolite-polyoxyalkylene-hemoglobin complex, highlight his role as an innovator. His work not only advances scientific knowledge but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile